Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.
Longboard Pharmaceuticals's investors include Cormorant Asset Management, Farallon Capital Management, T. Rowe Price, HBM Healthcare Investments, Highline Capital Management.
Longboard Pharmaceuticals is headquartered in San Diego, United States.
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.
Longboard Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Longboard Pharmaceuticals — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/longboard-pharmaceuticals. Accessed September 29, 2026.
VCBacked. (2024). Longboard Pharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/longboard-pharmaceuticals
{{cite web |title=Longboard Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/longboard-pharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated